147 related articles for article (PubMed ID: 12402292)
1. Fibronectin receptor reduction in skin and fibroblasts of patients with Ullrich's disease.
Hu J; Higuchi I; Shiraishi T; Suehara M; Niiyama T; Horikiri T; Uchida Y; Saito A; Osame M
Muscle Nerve; 2002 Nov; 26(5):696-701. PubMed ID: 12402292
[TBL] [Abstract][Full Text] [Related]
2. Abnormal expression of proteoglycans in Ullrich's disease with collagen VI deficiency.
Higashi K; Higuchi I; Niiyama T; Uchida Y; Shiraishi T; Hashiguchi A; Saito A; Horikiri T; Suehara M; Arimura K; Osame M
Muscle Nerve; 2006 Jan; 33(1):120-6. PubMed ID: 16258947
[TBL] [Abstract][Full Text] [Related]
3. [Collagenopathy (Ullrich congenital muscular dystrophy, Bethlem myopathy)].
Higuchi I
Rinsho Shinkeigaku; 2005 Nov; 45(11):935-7. PubMed ID: 16447767
[TBL] [Abstract][Full Text] [Related]
4. Pathological characteristics of skeletal muscle in Ullrich's disease with collagen VI deficiency.
Higuchi I; Horikiri T; Niiyama T; Suehara M; Shiraishi T; Hu J; Uchida Y; Saito A; Nakagawa M; Arimura K; Osame M
Neuromuscul Disord; 2003 May; 13(4):310-6. PubMed ID: 12868500
[TBL] [Abstract][Full Text] [Related]
5. Reduced cell anchorage may cause sarcolemma-specific collagen VI deficiency in Ullrich disease.
Kawahara G; Okada M; Morone N; Ibarra CA; Nonaka I; Noguchi S; Hayashi YK; Nishino I
Neurology; 2007 Sep; 69(10):1043-9. PubMed ID: 17785674
[TBL] [Abstract][Full Text] [Related]
6. Collagen VI status and clinical severity in Ullrich congenital muscular dystrophy: phenotype analysis of 11 families linked to the COL6 loci.
Demir E; Ferreiro A; Sabatelli P; Allamand V; Makri S; Echenne B; Maraldi M; Merlini L; Topaloglu H; Guicheney P
Neuropediatrics; 2004 Apr; 35(2):103-12. PubMed ID: 15127309
[TBL] [Abstract][Full Text] [Related]
7. [Collagen VI-related muscle disorders].
Higuchi I
Brain Nerve; 2011 Nov; 63(11):1169-78. PubMed ID: 22068469
[TBL] [Abstract][Full Text] [Related]
8. Frameshift mutation in the collagen VI gene causes Ullrich's disease.
Higuchi I; Shiraishi T; Hashiguchi T; Suehara M; Niiyama T; Nakagawa M; Arimura K; Maruyama I; Osame M
Ann Neurol; 2001 Aug; 50(2):261-5. PubMed ID: 11506412
[TBL] [Abstract][Full Text] [Related]
9. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
Iannone F; Matucci-Cerinic M; Falappone PC; Guiducci S; Cinelli M; Distler O; Lapadula G
J Rheumatol; 2005 Oct; 32(10):1893-8. PubMed ID: 16206343
[TBL] [Abstract][Full Text] [Related]
10. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy.
Baker NL; Mörgelin M; Peat R; Goemans N; North KN; Bateman JF; Lamandé SR
Hum Mol Genet; 2005 Jan; 14(2):279-93. PubMed ID: 15563506
[TBL] [Abstract][Full Text] [Related]
11. Capillary changes in skeletal muscle of patients with Ullrich's disease with collagen VI deficiency.
Niiyama T; Higuchi I; Hashiguchi T; Suehara M; Uchida Y; Horikiri T; Shiraishi T; Saitou A; Hu J; Nakagawa M; Arimura K; Osame M
Acta Neuropathol; 2003 Aug; 106(2):137-42. PubMed ID: 12736748
[TBL] [Abstract][Full Text] [Related]
12. Muscle interstitial fibroblasts are the main source of collagen VI synthesis in skeletal muscle: implications for congenital muscular dystrophy types Ullrich and Bethlem.
Zou Y; Zhang RZ; Sabatelli P; Chu ML; Bönnemann CG
J Neuropathol Exp Neurol; 2008 Feb; 67(2):144-54. PubMed ID: 18219255
[TBL] [Abstract][Full Text] [Related]
13. A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations.
Jimenez-Mallebrera C; Maioli MA; Kim J; Brown SC; Feng L; Lampe AK; Bushby K; Hicks D; Flanigan KM; Bonnemann C; Sewry CA; Muntoni F
Neuromuscul Disord; 2006 Oct; 16(9-10):571-82. PubMed ID: 16935502
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nonsense-mediated mRNA decay rescues the phenotype in Ullrich's disease.
Usuki F; Yamashita A; Higuchi I; Ohnishi T; Shiraishi T; Osame M; Ohno S
Ann Neurol; 2004 May; 55(5):740-4. PubMed ID: 15122717
[TBL] [Abstract][Full Text] [Related]
15. Electron microscopic abnormalities of skeletal muscle in patients with collagen VI deficiency in Ullrich's disease.
Niiyama T; Higuchi I; Suehara M; Hashiguchi T; Shiraishi T; Nakagawa M; Arimura K; Maruyama I; Osame M
Acta Neuropathol; 2002 Jul; 104(1):67-71. PubMed ID: 12070666
[TBL] [Abstract][Full Text] [Related]
16. Effect of dexamethasone on the assembly of the matrix of fibronectin and on its receptors organization in Ehlers-Danlos syndrome skin fibroblasts.
Zoppi N; Ghinelli A; Gardella R; Barlati S; Colombi M
Cell Biol Int; 1998; 22(7-8):499-508. PubMed ID: 10452818
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen.
Minamitani T; Ariga H; Matsumoto K
Exp Cell Res; 2004 Jul; 297(1):49-60. PubMed ID: 15194424
[TBL] [Abstract][Full Text] [Related]
18. [Merosin-positive congenital muscular dystrophy with early orthopaedic problems in relation to Ullrich's disease].
Chang S; Ishikawa T; Nonaka I; Tsukamoto H; Saito M; Ban K; Wada I; Sugie K; Nishino I
No To Hattatsu; 2003 Mar; 35(2):159-64. PubMed ID: 12661101
[TBL] [Abstract][Full Text] [Related]
19. A clinical and histological study of Ullrich's disease (congenital atonic-sclerotic muscular dystrophy).
Nonaka I; Une Y; Ishihara T; Miyoshino S; Nakashima T; Sugita H
Neuropediatrics; 1981 Aug; 12(3):197-208. PubMed ID: 7290342
[TBL] [Abstract][Full Text] [Related]
20. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
Postiglione L; Ladogana P; Montagnani S; di Spigna G; Castaldo C; Turano M; Bruno EM; Di Meglio F; Riccio A; Rossi G
J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
